TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31146957

Group type: EXPERIMENTAL
Intervention: Regular diet plus nutritional supplementation (arginine, glutamine, and fish oil)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 88
Study: 31207232

Group type: EXPERIMENTAL
Intervention: Guselkumab maintenance therapy
Number of subjects: 375

Group type: COMPARATOR
Intervention: Guselkumab withdrawal (placebo)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Guselkumab retreatment after withdrawal
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Cytokine levels (IL-17A, IL-17F, IL-22)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Cytokine levels (IL-23)
Number of subjects: 375
Study: 27871802

Group type: EXPERIMENTAL
Intervention: Probiotic treatment
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 26400431

Group type: EXPERIMENTAL
Intervention: Delphinol (maqui berry extract) 162 mg anthocyanins, taken 3 times daily for 4 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 23528153

Group type: EXPERIMENTAL
Intervention: Inflatable obstetric belt (Labor Assister, Baidy M‐520/Curexo, Inc.) during the second stage of labor
Number of subjects: 188

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Inflatable obstetric belt (Labor Assister)
Number of subjects: 188
Study: 21447950

Group type: EXPERIMENTAL
Intervention: CRA with vouchers
Number of subjects: 58

Group type: COMPARATOR
Intervention: CRA without vouchers
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 58
Study: 18319362

Group type: EXPERIMENTAL
Intervention: Not eating lunch at school in the sixth grade
Number of subjects: 1498

Group type: EXPERIMENTAL
Intervention: Eating lunch outside of school
Number of subjects: 1498
Study: 17454589

Group type: EXPERIMENTAL
Intervention: PEG‐IFNalpha‐2a, 450 microg once weekly
Number of subjects: 144

Group type: COMPARATOR
Intervention: IFNalpha‐2a, 9 MIU once daily
Number of subjects: 144
Study: 15157126

Group type: EXPERIMENTAL
Intervention: Music/Video
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Music-Only
Number of subjects: 86

Group type: COMPARATOR
Intervention: Video-Only
Number of subjects: 86

Group type: COMPARATOR
Intervention: No contact Control
Number of subjects: 86
Study: 12414849

Group type: EXPERIMENTAL
Intervention: 1 mg/d micronized E(2) (n = 12)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (PL; n = 13)
Number of subjects: 26
Study: 9466049

Group type: EXPERIMENTAL
Intervention: 13-cis-retinoic acid (1 mg/kg/day)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 7857585

Group type: EXPERIMENTAL
Intervention: Propranolol and ridazolol (beta-adrenoreceptor blockers)
Number of subjects: 42
Study: 2563608

Group type: EXPERIMENTAL
Intervention: VDU with strong electrostatic and electromagnetic fields
Number of subjects: 30

Group type: COMPARATOR
Intervention: VDU with eliminated electrostatic and electromagnetic fields
Number of subjects: 30

Group type: COMPARATOR
Intervention: VDU turned off (with cable present)
Number of subjects: 30
Study: 26

Group type: EXPERIMENTAL
Intervention: 15 mg Sch 1000
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 15 mg Sch 1000 + 10 mg oxazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: 10 mg oxazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30819238

Group type: EXPERIMENTAL
Intervention: Web-based personalised information and support system (WINS) (n = 53)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard care (n = 49)
Number of subjects: 102
Study: 28822837

Group type: COMPARATOR
Intervention: Active tDCS treatment in Phase II
Number of subjects: 42

Group type: COMPARATOR
Intervention: Active tDCS treatment in Phase I
Number of subjects: 42
Study: 25897156

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg for 6 weeks, 10 mg for 18 weeks)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study: 24311553

Group type: EXPERIMENTAL
Intervention: Interpersonal counselling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study: 21981869

Group type: EXPERIMENTAL
Intervention: Combined therapy using acupressure therapy, hypnotherapy, and transcendental meditation (TM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (2 capsules containing 3g of wheat flour each, taken morning and evening)
Number of subjects: 20
Study: 19019594

Group type: EXPERIMENTAL
Intervention: TASER X26 (5-s exposure)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Oleoresin capsicum (O.C.) (5-s spray to the eyes)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (45-s exposure of hand and forearm in 0 degrees C)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Defensive tactics drill (1-min drill)
Number of subjects: 4
Study: 17200238

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (10^8 live bacteria per day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Simethicone (60 mg/day)
Number of subjects: 90
Study: 15377853

Group type: EXPERIMENTAL
Intervention: Subjective burden before adjuvant therapy
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Better mood
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Gradient of beta2‐microglobulin
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Markers of activation of the cellular immune system
Number of subjects: 239
Study: 11865786

Group type: EXPERIMENTAL
Intervention: EMLA anesthetic cream applied for 15 minutes
Number of subjects: 48

Group type: COMPARATOR
Intervention: EMLA anesthetic cream applied for 30 minutes
Number of subjects: 48
Study: 9560034

Group type: EXPERIMENTAL
Intervention: Cholestatic infants
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Breastfed cholestatic infants
Number of subjects: 34
Study: 8163732

Group type: EXPERIMENTAL
Intervention: 20 mg/kg DMSA for 14 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: DMSA treatment
Number of subjects: 20
Study: 2828406

Group type: EXPERIMENTAL
Intervention: RU 486 (20 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cortisol (0.1 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: RU 486 and cortisol combination
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31899253

Group type: EXPERIMENTAL
Intervention: FCCH-based intervention (9-month duration, delivered through three workshops, three home visits, and nine phone calls)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Attention control arm (business-focused intervention)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: FCCH-based intervention
Number of subjects: 496
Study: 31125335

Group type: EXPERIMENTAL
Intervention: Bayesian Representational Similarity Analysis (BRSA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pattern Component Model (PCM)
Number of subjects: 0
Study: 28380151

Group type: EXPERIMENTAL
Intervention: Hammock position
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nesting
Number of subjects: 30
Study: 25840429

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 mcg) 1 hour prior to surgery
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 mcg) 3 hours prior to surgery
Number of subjects: 184

Group type: COMPARATOR
Intervention: Vaginal misoprostol (400 mcg) 1 hour prior to surgery
Number of subjects: 184

Group type: COMPARATOR
Intervention: Vaginal misoprostol (400 mcg) 3 hours prior to surgery
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Total priming time
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Administration route
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Administration route and priming time interaction
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Duration of surgery
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Amount of bleeding
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Rate of side effects (nausea, shivering)
Number of subjects: 184
Study: 23920419

Group type: EXPERIMENTAL
Intervention: Balloon dilation
Number of subjects: 92

Group type: COMPARATOR
Intervention: FESS
Number of subjects: 92
Study: 21438891

Group type: EXPERIMENTAL
Intervention: Enhanced Atrioventricular Search Hysteresis (AVSH)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Standard Atrioventricular Search Hysteresis (AVSH)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Enhanced Atrioventricular Search Hysteresis (AVSH) in patients with a history of AV block
Number of subjects: 178

Group type: COMPARATOR
Intervention: Standard Atrioventricular Search Hysteresis (AVSH) in patients with a history of AV block
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Overall patients experiencing > 20% relative %VP reduction
Number of subjects: 178
Study: 19728565

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of 135 mg amodiaquine and 50 mg artesunate administered after a high-fat breakfast
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fixed-dose combination of 135 mg amodiaquine and 50 mg artesunate administered in fasting state
Number of subjects: 22
Study: 17451691

Group type: COMPARATOR
Intervention: hCG
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: GnRH-agonist
Number of subjects: 228
Study: 15584055

Group type: EXPERIMENTAL
Intervention: Compression plus surgery
Number of subjects: 214

Group type: COMPARATOR
Intervention: Compression alone
Number of subjects: 214
Study: 11876716

Group type: EXPERIMENTAL
Intervention: Prucalopride
Number of subjects: 10
Study: 10201465

Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg q.d. and metronidazole extended‐release formulation 750 mg q.d. for 10 days (OM)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: OM plus amoxicillin 1.5 g q.d. for 10 days (OMAm)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: OM plus azithromycin 500 mg q.d. for 7 days (OMAz)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: OM plus clarithromycin 1 g q.d. for 10 days (OMCI)
Number of subjects: 160
Study: 7575985

Group type: EXPERIMENTAL
Intervention: Low air loss (LAL) therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard hospital mattress (SHM)
Number of subjects: 10
Study: 2391592

Group type: EXPERIMENTAL
Intervention: Low-CHO formula
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-CHO formula
Number of subjects: 12
Study: 6767824

Group type: EXPERIMENTAL
Intervention: Higher protein regimen of 3.6 gm/kg/day
Number of subjects: 82

Group type: COMPARATOR
Intervention: Lower protein regimen of 2.3 gm/kg/day
Number of subjects: 82

Group type: COMPARATOR
Intervention: Comparison of ChJ infants to long-term PN infants without ChJ
Number of subjects: 82
Study: 30531184

Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange
Number of subjects: 81

Group type: COMPARATOR
Intervention: No therapeutic plasma exchange
Number of subjects: 81
Study: 28093012

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program (n=79)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Standard care (n=82)
Number of subjects: 161
Study: 26334173

Group type: EXPERIMENTAL
Intervention: Endoscopic Sphincterotomy (EST)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Endoscopic Papillary Large Balloon Dilation (EPLBD)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Endoscopic Sphincterotomy plus Large Balloon Dilation (ESLBD)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: EPLBD
Number of subjects: 255
Study: 23691837

Group type: EXPERIMENTAL
Intervention: Part-task training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole-task training
Number of subjects: 0
Study: 21642610

Group type: EXPERIMENTAL
Intervention: Epidural lidocaine administration (20-35 mL) 1 hour before epidural EREM administration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Epidural EREM (8 mg)
Number of subjects: 30
Study: 19780401

Group type: EXPERIMENTAL
Intervention: Hypomagnesemia group
Number of subjects: 165

Group type: COMPARATOR
Intervention: Normo-magnesemic group
Number of subjects: 165

Group type: COMPARATOR
Intervention: Comparison of AUC between groups
Number of subjects: 165
Study: 16930385

Group type: EXPERIMENTAL
Intervention: Psycho-educational program
Number of subjects: 0
Study: 15568670

Group type: EXPERIMENTAL
Intervention: rabeprosole (pariet)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: omeprosole (omez)
Number of subjects: 20
Study: 11295623

Group type: EXPERIMENTAL
Intervention: Selenium (200 microg/day in selenized yeast)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selenium
Number of subjects: 0
Study: 9155504

Group type: EXPERIMENTAL
Intervention: High-MUFA meal (24% energy)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low-MUFA meal (12% energy)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Medium-MUFA meal (17% energy)
Number of subjects: 15
Study: 7681997

Group type: EXPERIMENTAL
Intervention: 18 Gy/3 fractions/3 days
Number of subjects: 216

Group type: COMPARATOR
Intervention: 25 Gy/10 fractions/14 days (second course)
Number of subjects: 216
Study: 3595691

Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFOS) 5 g/m2
Number of subjects: 171

Group type: COMPARATOR
Intervention: Cyclophosphamide (CYCLO) 1.5 g/m2
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFOS)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Cyclophosphamide (CYCLO)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFOS) and Cyclophosphamide (CYCLO)
Number of subjects: 171
Study: 29436078

Group type: EXPERIMENTAL
Intervention: Multisensory exercise programme (n = 24)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n = 21)
Number of subjects: 45
Study: 26331711

Group type: EXPERIMENTAL
Intervention: Pre-ESD eradication therapy (n = 44)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Post-ESD eradication therapy (n = 52)
Number of subjects: 96
Study: 24721289

Group type: EXPERIMENTAL
Intervention: Food advertising
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: High cognitive load with food advertising
Number of subjects: 351

Group type: COMPARATOR
Intervention: Non-food advertising
Number of subjects: 351

Group type: COMPARATOR
Intervention: Low cognitive load
Number of subjects: 351
Study: 23113531

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - reduced hoop diameter rim (0.35 m)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control Group (CG) - standard rim
Number of subjects: 18
Study: 21738668

Group type: EXPERIMENTAL
Intervention: sequential 2, 4 and 8‐week ART interruptions
Number of subjects: 53

Group type: COMPARATOR
Intervention: continuous ART (cART)
Number of subjects: 53
Study: 20049658

Group type: EXPERIMENTAL
Intervention: UV photography and skin cancer information intervention
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: UV photography and photoaging information intervention
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 148
Study: 16566623

Group type: EXPERIMENTAL
Intervention: EX/RP+CMI
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: EX/RP
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: CMI
Number of subjects: 122

Group type: COMPARATOR
Intervention: PBO
Number of subjects: 122
Study: 12770651

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative administration of atenolol
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Intraoperative atenolol as a major component of the anesthetic regimen
Number of subjects: 59

Group type: COMPARATOR
Intervention: Perioperative management without beta‐adrenergic antagonism
Number of subjects: 59
Study: 10894377

Group type: EXPERIMENTAL
Intervention: Core decompression (surgical treatment)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Conservative treatment (control group)
Number of subjects: 9
Study: 9298605

Group type: EXPERIMENTAL
Intervention: 0.02% benzalkonium chloride
Number of subjects: 65

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 65

Group type: COMPARATOR
Intervention: Fluticasone propionate aqueous nasal spray
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (0.02% benzalkonium chloride without fluticasone)
Number of subjects: 65
Study: 8336255

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser irradiation (20 W for 0.3, 0.5, 1.0, 2.0, or 3.0 seconds)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Citric acid treatment (saturated, pH 1 for 3 minutes)
Number of subjects: 15
Study: 3342628

Group type: EXPERIMENTAL
Intervention: Alcohol cleansing followed by application of an iodophor‐impregnated sterile film
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional iodophor skin cleansing
Number of subjects: 60
Study: 29193548

Group type: EXPERIMENTAL
Intervention: Pre-hospital blood product (PHBP) administration (up to two units of red blood cells and two units of lyophilised plasma)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Standard care (up to four boluses of 250 mL 0.9% saline)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Pre-hospital blood product (PHBP) administration
Number of subjects: 490
Study: 26794694

Group type: EXPERIMENTAL
Intervention: Pd‐Ag‐In alloy crowns
Number of subjects: 35

Group type: COMPARATOR
Intervention: Gold alloy crowns
Number of subjects: 35

Group type: COMPARATOR
Intervention: Zirconia crowns
Number of subjects: 35
Study: 25611944

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention (≥5% weight loss)
Number of subjects: 390
Study: 23746429

Group type: EXPERIMENTAL
Intervention: E-cigarette use
Number of subjects: 4444
Study: 21969577

Group type: COMPARATOR
Intervention: H2A histone family, member Y (H2AFY) overexpression in blood and frontal cortex of HD patients
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Histone deacetylase inhibitor
Number of subjects: 119
Study: 18359746

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 61

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Type 2 diabetics
Number of subjects: 61
Study: 16437275

Group type: EXPERIMENTAL
Intervention: Virtual Reality Simulator (SIMENDO)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional Box Trainer
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Experts (>100 endoscopic procedures)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Novices (no experience)
Number of subjects: 75
Study: 12641642

Group type: EXPERIMENTAL
Intervention: Kistler 9861A force platform (KIS)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Chattecx Balance System (CBS)
Number of subjects: 29
Study: 10572797

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate and topical dexamethasone (n = 34)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Dexamethasone ointment (n = 22)
Number of subjects: 56
Study: 9065279

Group type: EXPERIMENTAL
Intervention: Preoperative hormone therapy
Number of subjects: 7

Group type: COMPARATOR
Intervention: No preoperative hormone therapy (Control)
Number of subjects: 7
Study: 1860293

Group type: EXPERIMENTAL
Intervention: Topical varnish containing strontium chloride
Number of subjects: 10

Group type: COMPARATOR
Intervention: Varnish application with no active ingredient (placebo)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Untreated teeth
Number of subjects: 10
Study: 6751143

Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive pressure ventilation with a bag and mask
Number of subjects: 0
Study: 31872552

Group type: EXPERIMENTAL
Intervention: Follicle-stimulating hormone (FSH) treatment, specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical endocrinological approach (substitutive regimen for hypogonadotropic hypogonadism), specific details not mentioned.
Number of subjects: 0
Study: 30182858

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP) 5-10 mg TID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: acetyl-DL-leucine
Number of subjects: 0

Group type: COMPARATOR
Intervention: sustained-release (SR) form of 4-AP
Number of subjects: 0

Group type: COMPARATOR
Intervention: SR form of 4-AP
Number of subjects: 0
Study: 28062251

Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.7ng/ml target-controlled infusion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 25613351

Group type: EXPERIMENTAL
Intervention: Bilateral subthalamic nucleus (STN) DBS + Optimal Drug Therapy (ODT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Optimal Drug Therapy (ODT)
Number of subjects: 30
Study: 23083831

Group type: EXPERIMENTAL
Intervention: Dinoprostone intravaginal suppository
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21457679

Group type: EXPERIMENTAL
Intervention: TAU plus brief behavioral therapy for insomnia (4 weekly 1-hour sessions)
Number of subjects: 37

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 37
Study: 19269744

Group type: EXPERIMENTAL
Intervention: Heterotopic noxious conditioning stimulation (HNCS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 17350395

Group type: EXPERIMENTAL
Intervention: Robotic Telepresence (RTP)
Number of subjects: 0
Study: 15076931

Group type: EXPERIMENTAL
Intervention: Intravaginal practices (including wiping, douching, or inserting substances into the vagina)
Number of subjects: 2897
Study: 11339068

Group type: EXPERIMENTAL
Intervention: Manual method of RBC collection
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Apheresis procedure of RBC collection
Number of subjects: 5
Study: 9476458

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin (single dose)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Procaine penicillin (7-day regimen)
Number of subjects: 176
Study: 7944693

Group type: EXPERIMENTAL
Intervention: Video-assisted techniques
Number of subjects: 67

Group type: COMPARATOR
Intervention: Muscle-sparing procedures
Number of subjects: 67
Study: 3410630

Group type: EXPERIMENTAL
Intervention: 24-week progressive strength training
Number of subjects: 21
Study: 29717075

Group type: EXPERIMENTAL
Intervention: Case-based discussion after lecture
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Case-based discussion before lecture
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no case-based discussion)
Number of subjects: 52
Study: 28245726

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg orally each night for 28 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo each night for 28 days
Number of subjects: 18